These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36805072)

  • 1. Implementation of risk enhancers in ASCVD risk estimation and hypolipidemic treatment eligibility: A sex-specific analysis.
    Georgiopoulos G; Delialis D; Aivalioti E; Georgakis V; Mavraganis G; Angelidakis L; Bampatsias D; Armeni E; Maneta E; Patras R; Dimopoulou MA; Oikonomou E; Kanakakis I; Lambrinoudaki I; Lagiou A; Xenos P; Stamatelopoulos K
    Hellenic J Cardiol; 2023; 73():16-23. PubMed ID: 36805072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remnant cholesterol and atherosclerotic disease in high cardiovascular risk patients. Beyond LDL cholesterol and hypolipidemic treatment.
    Delialis D; Georgiopoulos G; Aivalioti E; Mavraganis G; Dimopoulou AM; Sianis A; Aggelidakis L; Patras R; Petropoulos I; Ioannou S; Syrigou R; Chatzidou S; Kanakakis I; Stellos K; Stamatelopoulos K
    Hellenic J Cardiol; 2022; 66():26-31. PubMed ID: 35667617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid Plaque Composition and Prediction of Incident Atherosclerotic Cardiovascular Disease.
    van der Toorn JE; Bos D; Ikram MK; Verwoert GC; van der Lugt A; Ikram MA; Vernooij MW; Kavousi M
    Circ Cardiovasc Imaging; 2022 Mar; 15(3):e013602. PubMed ID: 35196868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study.
    Quispe R; Michos ED; Martin SS; Puri R; Toth PP; Al Suwaidi J; Banach M; Virani SS; Blumenthal RS; Jones SR; Elshazly MB
    J Am Heart Assoc; 2020 Feb; 9(3):e013600. PubMed ID: 32013698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Chevli PA; Islam T; Pokharel Y; Rodriguez F; Virani SS; Blaha MJ; Bertoni AG; Budoff M; Otvos JD; Shapiro MD
    J Clin Lipidol; 2022; 16(6):870-877. PubMed ID: 36180367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A machine learning based approach to identify carotid subclinical atherosclerosis endotypes.
    Chen QS; Bergman O; Ziegler L; Baldassarre D; Veglia F; Tremoli E; Strawbridge RJ; Gallo A; Pirro M; Smit AJ; Kurl S; Savonen K; Lind L; Eriksson P; Gigante B
    Cardiovasc Res; 2023 Dec; 119(16):2594-2606. PubMed ID: 37475157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is carotid artery evaluation necessary for primary prevention in asymptomatic high-risk patients without atherosclerotic cardiovascular disease?
    Kim G; Youn HJ; Choi YS; Jung HO; Chung WS; Kim CM
    Clin Interv Aging; 2015; 10():1111-9. PubMed ID: 26185430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Relationship between Atherosclerotic Cardiovascular Disease Risk Score and Carotid Artery Imaging Findings.
    Li Y; Zhu G; Ding V; Huang Y; Jiang B; Ball RL; Rodriguez F; Fleischmann D; Desai M; Saloner D; Saba L; Hom J; Wintermark M
    J Neuroimaging; 2019 Jan; 29(1):119-125. PubMed ID: 30357980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of atherosclerosis, arterial stiffness and related risk factors in chronic hemodialysis patients in Siriraj Hospital.
    Rattanasompattikul M; Chanchairujira K; On-Ajyooth L; Chanchairujira T
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S117-24. PubMed ID: 21721437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-sensitivity C-reactive protein is independently associated with early carotid artery progression in women but not in men: the INVADE Study.
    Sander K; Horn CS; Briesenick C; Sander D;
    Stroke; 2007 Nov; 38(11):2881-6. PubMed ID: 17885262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Coronary Plaque With Low-Density Lipoprotein Cholesterol Levels and Rates of Cardiovascular Disease Events Among Symptomatic Adults.
    Mortensen MB; Caínzos-Achirica M; Steffensen FH; Bøtker HE; Jensen JM; Sand NPR; Maeng M; Bruun JM; Blaha MJ; Sørensen HT; Pareek M; Nasir K; Nørgaard BL
    JAMA Netw Open; 2022 Feb; 5(2):e2148139. PubMed ID: 35147685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric form of C-reactive protein in the assessment of the residual inflammatory cardiovascular risk in patients with subclinical carotid atherosclerosis.
    Melnikov IS; Kozlov SG; Pogorelova OA; Tripoten MI; Saburova OS; Khamchieva LS; Avtaeva YN; Zvereva MD; Prokofieva LV; Kuznetsova TV; Guseva OA; Balakhonova TV; Gabbasov ZA
    Kardiologiia; 2022 Jul; 62(7):24-30. PubMed ID: 35989626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carotid Atherosclerosis, Microalbuminuria, and Estimated 10-Year Atherosclerotic Cardiovascular Disease Risk in Sub-Saharan Africa.
    Nonterah EA; Boateng D; Crowther NJ; Klipstein-Grobusch K; Oduro AR; Agongo G; Mohamed SF; Boua PR; Choma SSR; Norris SA; Tollman SM; Bots ML; Ramsay M; Grobbee D
    JAMA Netw Open; 2022 Apr; 5(4):e227559. PubMed ID: 35471573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PCSK9 Inhibition in Atherosclerotic Cardiovascular Disease.
    Delialis D; Dimopoulou MA; Papaioannou M; Kotsira G; Maneta E; Mavraganis G; Loutos C; Georgiopoulos G; Stamatelopoulos K
    Curr Pharm Des; 2023; 29(23):1802-1824. PubMed ID: 37055909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.
    Han D; Berman DS; Miller RJH; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; Marques H; de Araújo Gonçalves P; Gottlieb I; Hadamitzky M; Leipsic J; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Lee SE; Virmani R; Samady H; Stone P; Narula J; Bax JJ; Shaw LJ; Lin FY; Min JK; Chang HJ
    JAMA Netw Open; 2020 Jul; 3(7):e2011444. PubMed ID: 32706382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum inflammatory biomarkers with plaque inflammation assessed by FDG PET/CT: the dal-PLAQUE study.
    Duivenvoorden R; Mani V; Woodward M; Kallend D; Suchankova G; Fuster V; Rudd JHF; Tawakol A; Farkouh ME; Fayad ZA
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1087-1094. PubMed ID: 24135322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokines: a novel link between adiposity and carotid plaque vulnerability.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Kostakis A; Liapis CD
    Eur J Clin Invest; 2012 Dec; 42(12):1278-86. PubMed ID: 23033969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory Obesity Phenotypes, Gender Effects, and Subclinical Atherosclerosis in African Americans: The Jackson Heart Study.
    Lin A; Lacy ME; Eaton C; Correa A; Wu WC
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2431-2438. PubMed ID: 27856456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Slightly elevated high-sensitivity C-reactive protein (hsCRP) concentrations are associated with carotid atherosclerosis in women with varying degrees of glucose tolerance.
    Prahl U; Wikstrand J; Bergström GM; Behre CJ; Hulthe J; Fagerberg B
    Angiology; 2010 Nov; 61(8):793-801. PubMed ID: 20547540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.